Pharmafile Logo
Pharmafocus logo
Advanced Search
condom-3197506_960_720

Cases of sexually transmitted infections on the rise in England, data shows

June 5, 2019
Research and Development HIV, STDs, STIs, pharma PrEP, public health

Cases of sexually transmitted infections (STIs) are on the rise, according to new data from Public Health England. There were …

News
vertex-headquarters

Parents of children with cystic fibrosis start Orkambi buyers club

June 5, 2019
Research and Development NHS, Orkambi, Vertex, cystic fibrosis

Parents of children with cystic fibrosis have started an Orkambi buyers’ club to import generic versions of Vertex’s drug from …

News
lilly_entrance_web

Eli Lilly’s Emgality approved in the US for episodic cluster headache

June 5, 2019
Research and Development, Sales and Marketing Eli Lilly, Emgality, episodic cluster headache, migraine, pharma

Eli Lilly’s Emgality (galcanezumab-gnlm) self-administered injection solution has secured approval in the US for the treatment of episodic cluster headache, …

News
dr_zhang

NeoImmuneTech names experienced pharma exec Dr Samuel Zhang as company’s new Chief Business Officer

June 4, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Maryland-based biotech NeoImmuneTech has named Dr Samuel Zhang as the company’s new Chief Business Officer (CBO). Dr Zhang brings to …

Appointment
scott_gottlieb

Former FDA Commissioner returns to venture capital firm

June 4, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, Scott Gottlieb, appointment, pharma

Dr Scott Gottlieb, former Commissioner for the FDA, has returned to his venture capital background with the announcement that he …

Appointment
shutterstock_159488225

Darzalex combo makes strong Phase 3 showing in multiple myeloma

June 4, 2019
Manufacturing and Production, Research and Development ASCO 2019, Cancer, Janssen, darzalex, multiple myeloma, pharma

Janssen joined its contemporaries at the 55th American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago in the release …

News
janssen_latest_logo_on_sign

Janssen’s Imbruvica shows superiority in Phase 3 trials

June 4, 2019
Manufacturing and Production Janssen, imbruvia, leukaemia, pharma, phase 3, trial

Phase 3 data from ASCO 2019 has shown Janssen’s leukaemia drug Imbruvica (ibrutinib) had significant benefits over ofatumumab. In the …

News
amgen_flag

Amgen’s novel KRAS inhibitor monotherapy shows promise at Phase 1 in advanced solid tumours

June 4, 2019
Manufacturing and Production, Research and Development, Sales and Marketing Amgen, Cancer, KRAS

Amgen has unveiled the first clinical data for its investigational KRAS inhibitor AMG 510, the first such therapy to reach …

News

EMA approves Bluebird Bio’s gene therapy Zynteglo

June 4, 2019
Manufacturing and Production Bluebird Bio, European comission, gene therapy, health, pharma

The European Commission has granted a conditional marketing authorisation to bluebird bio’s gene therapy Zynteglo. The Massachusetts-based firm’s one time …

News

Walmart join MediLedger medical supply chain blockchain network

June 3, 2019
Manufacturing and Production MediLedger, blockchain, medical supply chain, pharma

Walmart has joined the MediLedger network – a network of pharma firms who use a permissioned blockchain to manage the …

News

Working Life: Monika Pocinkova, Vice President, HR Speciality Care, Ipsen UK & Ireland

June 3, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Working Life, feature, pharma

Ipsen’s Vice President of HR Speciality Care discusses the path she has taken throughout her career, the cultural differences she …

Feature
janssen_latest_logo_on_sign_closer

Janssen’s Erleada combo smashes endpoints in advanced hormone-sensitive prostate cancer

June 3, 2019
Research and Development, Sales and Marketing ASCO 2019, Cancer, Erleada, Janssen, prostate cancer

Janssen joined the showing at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago to present new …

News

Isatuximab improves on standard of care treatments for multiple myeloma

June 3, 2019
Sales and Marketing Cancer, Immunogen, Sanofi, isatuximab, multiple myeloma, pharma

Sanofi and ImmunoGen’s isatuximab combination therapy prolonged progression free survival by five months compared to standard of care treatments in …

News
merckentranceweb

Longest follow up trial of Merck’s Keytruda sets new standard for five year survival in lung cancer

June 3, 2019
Sales and Marketing KEYNOTE, MSD, Merck, keytruda, lung cancer

Nearly a quarter of previously untreated lung cancer patients who took Keytruda (Pembrolizumab) were alive after five years, according to …

News

Novartis’ Kisqali combo boosts survival in HR+/HER2- advanced breast cancer

June 3, 2019
Research and Development, Sales and Marketing Cancer, Kisqali, Novartis, breast cancer, pharma

Novartis took the opportunity at this year’s American Society of Clinical Oncology (ASCO) Annual Meeting to reveal new Phase 3 …

News

Healthcare would be ‘on the table’ in post-Brexit trade negotiations with US, Trump’s ambassador says

June 3, 2019
Sales and Marketing J&J, JJ, NHS, UK, US, brexit, healthcare

The American Ambassador to the United Kingdom has said that Britain’s healthcare system would be ‘on the table’ in post-Brexit …

News
dietmar_berger

Dr Dietmar Berger returns to big pharma

May 31, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Atara, R&D, Sanofi, oncology, pharma, research

Industry veteran Dr Dietmar Berger has joined Sanofi as the company’s new Global Head of Development. Dr Berger joins the …

Appointment
biogen_austria_238

Biogen’s diroximel fumarate impresses at Phase 3 in relapsing multiple sclerosis

May 31, 2019
Medical Communications, Research and Development Biogen, diroximel fumarate, multiple sclerosis, pharma, relapsingg multiple sclerosis

New data for Biogen’s investigational therapy diroximel fumarate has been revealed at the Consortium of Multiple Sclerosis Centers (CMSC) in …

News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

May 31, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing China, FDA, GSK, Novartis, Pfizer, environment, opioids, pharma, pricing

The pharmaceutical industry is a big polluter than the automotive industry. This was our top story this week. The findings …

News
nice_new_london_office_internal_2_8

RCP calls on NICE to update guidelines on coming off antidepressants

May 31, 2019
Medical Communications Guidelines, NICE, RCP, antidepressants, health, pharma

Guidance for patients on coming off antidepressants needs to be updated, according to the Royal College of Psychiatrists (RCP). Current …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026